$4.82
-0.13-2.63%
Last update: Oct 30, 7:49 PM
Savara Inc (SVRA) Stock Price, Quote, News & History
SVRANASDAQ
U.S. stocks fell, while BKV surged 9.2% on an equipment contract announcement; Penguin Solutions led gainers with a 16.3% jump on strong results.
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Other companies in Savara’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Savara has a consensus price target of $8.71.
The stock price for Savara (NASDAQ: SVRA) is $4.87 last updated October 30, 2026 at 7:49 PM EDT.
There are no upcoming dividends for Savara.
Savara does not have any upcoming earnings scheduled.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled...
